Strategic position Inova Diagnostics is a private, San Diego based leader in autoimmune diagnostic technologies and is part of Werfen, a global IVD player. This positioning suggests potential alignment opportunities within Werfen’s broader hospital and laboratory network to expand distribution and co-market advanced autoimmune testing solutions.

FDA cleared growth Recent FDA 510(k) clearances for the Aptiva System and Aptiva Celiac Disease IgA assay indicate a validated, expandable platform with regulatory credibility. This creates upsell opportunities to labs upgrading from older systems and to new customers seeking compliant, high-throughput autoimmune testing.

Diverse portfolio A comprehensive suite spanning diagnosis, stratification, and monitoring of autoimmune and related conditions (connective tissue disease, RA, antiphospholipid syndrome, vasculitis, celiac disease) enables cross-sell of complementary reagents and assays to existing customers and hospital networks with multi-disease testing needs.

Global hospital focus As part of Werfen with a long-term hospital/lab commitment, there are clear channel advantages for broad institutional adoption, inclusion in procurement contracts, and access to international labs seeking standardized autoimmunity panels.

Growth signals Revenue range and notable product launches over the years, plus ongoing manufacturing and ELISA process improvements through partnerships, point to a scalable growth trajectory. This suggests opportunity for incremental deals around system upgrades, reagent packs, and service agreements with mid to large laboratories.